RECLAZEPAM
UNII YJL42911RA

Substance Identification & Data

This profile provides standardized clinical and technical data for Reclazepam, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YJL42911RA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 76053-16-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YJL42911RA

CAS Registry Number

76053-16-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RECLAZEPAM

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H13Cl2N3O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MQGIGGJUPITZSE-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C74186

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

3052777

Unique identification number in the NCBI database of chemical substances.

INN ID

5743

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

W-79

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1(N2CCN=C(c3ccccc3Cl)c4cc(Cl)ccc42)=NC(CO1)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Reclazepam. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.